Robert W. Baird Analysts Give INC Research Holdings, Inc. (INCR) a $46.00 Price Target

INC Research Holdings, Inc. (NASDAQ:INCR) has been assigned a $46.00 price objective by equities researchers at Robert W. Baird in a note issued to investors on Thursday. The brokerage presently has a “buy” rating on the stock. Robert W. Baird’s target price suggests a potential upside of 27.78% from the company’s previous close.

INCR has been the subject of several other reports. Credit Suisse Group decreased their price target on shares of INC Research Holdings from $68.00 to $54.00 and set an “outperform” rating for the company in a research report on Tuesday. KeyCorp reissued a “market perform” rating and set a $46.00 price target (down from $68.00) on shares of INC Research Holdings in a research report on Monday. Jefferies Group LLC reaffirmed a “buy” rating and issued a $55.00 price objective on shares of INC Research Holdings in a research report on Friday, November 10th. TheStreet raised shares of INC Research Holdings from a “c” rating to a “b-” rating in a research report on Monday, November 6th. Finally, Zacks Investment Research lowered shares of INC Research Holdings from a “buy” rating to a “hold” rating in a research report on Wednesday, October 4th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $56.33.

INC Research Holdings (NASDAQ INCR) opened at $36.00 on Thursday. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.27 and a current ratio of 1.27. The firm has a market cap of $3,584.25, a price-to-earnings ratio of 15.76, a price-to-earnings-growth ratio of 0.90 and a beta of 1.36. INC Research Holdings has a 1 year low of $33.60 and a 1 year high of $61.10.

INC Research Holdings (NASDAQ:INCR) last posted its quarterly earnings results on Thursday, November 9th. The company reported $0.54 EPS for the quarter, missing the Zacks’ consensus estimate of $0.63 by ($0.09). The company had revenue of $592.21 million during the quarter, compared to the consensus estimate of $604.95 million. INC Research Holdings had a positive return on equity of 14.42% and a negative net margin of 4.29%. The company’s revenue for the quarter was up 128.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.64 earnings per share. equities research analysts expect that INC Research Holdings will post 2.29 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/11/16/robert-w-baird-analysts-give-inc-research-holdings-inc-incr-a-46-00-price-target.html.

In other news, CEO Alistair Macdonald sold 2,348 shares of INC Research Holdings stock in a transaction on Monday, September 18th. The stock was sold at an average price of $54.60, for a total transaction of $128,200.80. Following the transaction, the chief executive officer now owns 99,453 shares in the company, valued at approximately $5,430,133.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Gregory S. Rush sold 41,420 shares of INC Research Holdings stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $58.26, for a total value of $2,413,129.20. Following the transaction, the chief financial officer now owns 42,793 shares in the company, valued at approximately $2,493,120.18. The disclosure for this sale can be found here. Insiders sold a total of 189,493 shares of company stock worth $11,059,514 in the last three months. 0.24% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Lee Thomas H Partners LP acquired a new position in INC Research Holdings in the third quarter valued at approximately $1,316,644,000. BlackRock Inc. boosted its holdings in INC Research Holdings by 40,517.6% in the first quarter. BlackRock Inc. now owns 3,544,294 shares of the company’s stock valued at $162,506,000 after purchasing an additional 3,535,568 shares in the last quarter. Janus Henderson Group PLC purchased a new stake in INC Research Holdings in the second quarter valued at approximately $99,424,000. State Street Corp lifted its stake in INC Research Holdings by 112.8% in the second quarter. State Street Corp now owns 1,769,353 shares of the company’s stock valued at $103,508,000 after buying an additional 937,864 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its stake in INC Research Holdings by 1,337.6% in the third quarter. Point72 Asset Management L.P. now owns 598,039 shares of the company’s stock valued at $31,277,000 after buying an additional 556,439 shares during the last quarter. 77.75% of the stock is owned by institutional investors.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Analyst Recommendations for INC Research Holdings (NASDAQ:INCR)

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply